Sk Majid Box

Antibiotic resistance has emerged as a global public health crisis in the 21st century, leading to treatment failures. To address this issue, the medical and pharmaceutical sectors are confronted with two challenges: i) finding potent new antimicrobial agents that would work against resistant–pathogens, and ii) developing conceptually new or unconventional strategies by which a particular antibiotic would remain effective persistently.